Faculty

Information Session: Master’s and Doctoral Scholar Awards

emily.cholette2@mcgill.ca — Fri, 09 May 2025 11:00:00 +0000

Are you a Master's or Doctoral student interested in applying for a D2R Scholar Award?

Call for proposals: Master’s and Doctoral Scholar Awards

emily.cholette2@mcgill.ca — Fri, 09 May 2025 11:00:00 +0000

D2R launches a call for applications for the Master’s and Doctoral Scholar Awards funding program.

A foundational goal of D2R is to help cultivate the next generation of researchers. Being a D2R Scholar is the highest recognition available to D2R trainees and the awards recognize outstanding and active trainees performing research across all of D2R’s Foundational Axes.

Symposium on the implementation of precision medicine in healthcare

emily.cholette2@mcgill.ca — Tue, 29 Apr 2025 18:01:45 +0000

A perspective from Estonia and Canada

The future of genomic medicine and its implications for RNA therapies

emily.cholette2@mcgill.ca — Mon, 31 Mar 2025 15:42:12 +0000

On this page :

Call for proposals: Foundational and Research in Motion

emily.cholette2@mcgill.ca — Thu, 03 Apr 2025 18:09:49 +0000

D2R is pleased to launch the call for proposals for the Foundational and Research in Motion funding program.

This program integrates two previously separate funding programs - Foundational Projects and Research in Motion (RIM) - into a single, unified call. This program provides researchers with the flexibility to explore novel ideas and develop cutting-edge solutions that have the potential to lead to commercialization or clinical application.

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

emily.cholette2@mcgill.ca — Wed, 26 Mar 2025 11:00:00 +0000

Montreal, March 26, 2025 – ��ϲ�� University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

D2R Research Symposium 2025

emily.cholette2@mcgill.ca — Wed, 19 Feb 2025 19:53:20 +0000

Bringing the D2R community together!

Lunch & Learn with D2R and Axelys: Propelling RNA Research into Commercial Success

emily.cholette2@mcgill.ca — Thu, 27 Feb 2025 22:22:08 +0000

About the event:

Insights into the Role of Partnerships and Entrepreneurship for RNA-based Therapies

D2R webinar: Opportunities and challenges of Black people in RNA research

emily.cholette2@mcgill.ca — Wed, 22 Jan 2025 14:38:50 +0000

Join us for D2R’s Black History Month webinar: Opportunities and challenges of Black people in RNA research on Wednesday, February 12, 2025 from 12 to 1pm EST.

��ϲ�� awards $500,000 to accelerate Mpox research and vaccine development

emily.cholette2@mcgill.ca — Thu, 13 Feb 2025 12:00:00 +0000

Montreal, February 13, 2025 – ��ϲ�� University’s DNA to RNA Initiative (D2R) and ��ϲ�� Interdisciplinary Initiative in Infection and Immunity (MI4) have awarded $500,000 to fund five high-impact research projects aimed at advancing the understanding of Mpox through its Rapid Response for Mpox Research funding program.

D2R awards over $6 million to support Core Platforms

emily.cholette2@mcgill.ca — Fri, 07 Feb 2025 14:30:00 +0000

The D2R (DNA to RNA) Initiative has awarded more than $6 million to support eight Core Platforms at ��ϲ�� University and one at the University of British Columbia through its Core Platform Sustainability funding program. This program supports state-of-the-art Core Platforms that are essential for advancing research and development and facilitating technology uptake and transfer in fields relevant to RNA therapeutics.

Industry Insights with etherna

emily.cholette2@mcgill.ca — Fri, 10 Jan 2025 16:58:14 +0000

On this page:

D2R announces new round of funding, investing $1.5 million to advance research in RNA therapeutics and to support ��ϲ�� Centres and Institutes

emily.cholette2@mcgill.ca — Thu, 19 Dec 2024 14:21:57 +0000

Montreal – December 19, 2024 – The D2R (DNA to RNA) Initiative is proud to announce the recipients of its latest round of funding, awarding a total of $1.5 million to four principal investigators and five ��ϲ�� University Centres and Institutes. These awards are designed at advancing research in RNA therapeutics by facilitating industry collaboration and supporting the next generation of scientific leaders as well as research Centres and Institutes.

Remembering Emil Skamene (1941–2024), pioneer in genetic research at ��ϲ�� University

emily.cholette2@mcgill.ca — Mon, 06 Jan 2025 17:13:51 +0000

It is with deep sadness that we remember Emil Skamene, a pioneer in genetic research at ��ϲ�� University.

His groundbreaking work on host genetic susceptibility to infections has shaped the field for over three decades.

Skamene’s legacy continues to inspire scientists, including D2R’s Chief Scientific Officer, Philippe Gros, who, alongside Professor Erwin Schurr, honors him in a heartfelt eulogy published in Nature Genetics.

https://www.nature.com/articles/s41588-024-02028-7

CQDM partners with D2R to enhance collaborations among researchers and industry in RNA research

emily.cholette2@mcgill.ca — Thu, 28 Nov 2024 14:00:00 +0000

Montréal, November 28th – CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at ��ϲ�� University, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies. It aims to provide patients with safer and more effective therapeutic options, particularly for treating cancer, rare diseases, and preventing various infectious diseases.